We welcome conversations with pharma and biotech companies, clinicians, researchers, and other potential partners interested in PACAB-002 or our nanoparticle drug delivery platform for the delivery of hydrophobic and hard-to-deliver molecules.
We welcome conversations with pharma and biotech companies, clinicians, researchers, and other potential partners interested in PACAB-002 or our nanoparticle drug delivery platform for the delivery of hydrophobic and hard-to-deliver molecules.